“…However, as precision improves and prescription dose increases, segmentation error and variability in target volume definition can have greater impact on treatment efficacy. Segmentation-related errors including inter-and intra-observer variability has been demonstrated with respect to lung cancer in 3D image acquisition (Giraud et al 2002, Van de Steene et al 2002. Clinical margins exist to account for internal motion of the tumour volume, setup error, geographic miss of the target volume and irradiation of healthy tissue, however, if variability and segmentation-related error exceeds the clinical margins, patient outcomes and treatment efficacy can be compromised.…”